Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for FYs 2021-2025, 8310-8311 [2020-02919]

Download as PDF 8310 Federal Register / Vol. 85, No. 30 / Thursday, February 13, 2020 / Notices after October 1, 1995, unless it displays a currently valid OMB control number. In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. Proposed Collection: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI), 0925–0642, EXTENSION, National Cancer Institute on areas where communication, training or changes in operations might improve delivery of products or services. It also allows feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance provides useful information but it will not yield data that can be generalized to the overall population. OMB approval is requested for 3 year. There are no costs to respondents other than their time. The total estimated annualized burden hours are 9,337. (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This information collection activity is collecting qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration’s commitment to improving service delivery. This generic provides information about the National Cancer Institute’s customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention ESTIMATED ANNUALIZED BURDEN HOURS Surveys ................................................................. In-Depth Interviews (IDIs) or Small Discussion Groups. Focus Groups ....................................................... Website or Software Usability Tests .................... Individuals ..................... Individuals ..................... 27,100 500 1 1 12/60 90/60 5,420 750 Individuals ..................... Individuals ..................... 1000 5000 1 1 90/60 20/60 1,500 1,667 Total ............................................................... ....................................... ........................ 33,600 ........................ 9,337 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for FYs 2021–2025 AGENCY: National Institutes of Health, HHS. ACTION: Notice. This Request for Information (RFI) is intended to gather broad public input to assist the National Institutes of Health (NIH) in developing the NIHWide Strategic Plan for Fiscal Years (FYs) 2021–2025. NIH invites input from stakeholders throughout the scientific research, advocacy, and clinical practice communities, as well as the general public, regarding the proposed framework for the FY 2021– 2025 NIH-Wide Strategic Plan. Organizations are strongly encouraged to submit a single response that reflects the views of their organization and their membership as a whole. SUMMARY: VerDate Sep<11>2014 18:34 Feb 12, 2020 Jkt 250001 This RFI is open for public comment for a period of 6 weeks. Comments must be received by 11:59:59 p.m. (ET) on March 25, 2020 to ensure consideration. ADDRESSES: All comments must be submitted electronically on the submission website, available at https:// grants.nih.gov/grants/rfi/rfi.cfm?ID=101. FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to: Marina Volkov, nihstrategicplan@od.nih.gov, 301.496.4147. DATES: [FR Doc. 2020–02913 Filed 2–12–20; 8:45 am] jbell on DSKJLSW7X2PROD with NOTICES Average burden per response (in hours) Type of respondent Dated: February 5, 2020. Diane Kreinbrink, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. Number of respondents Number of responses per respondent Form name The purpose of the NIH-Wide Strategic Plan is to communicate how NIH will advance its mission to support research in pursuit of fundamental knowledge about the nature and behavior of living systems, and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The current NIH-Wide Strategic Plan (available at: https://www.nih.gov/ about-nih/nih-wide-strategic-plan), covering FYs 2016–2020, was submitted to Congress on December 15, 2015. As part of implementing the 21st Century Cures Act (Pub. L. 114–255), NIH will update its Strategic Plan every five years. The agency is currently developing an updated NIH-Wide Strategic Plan, for FYs 2021–2025, and anticipates releasing it in December 2020. The FY 2021–2025 NIH-Wide Strategic Plan will highlight NIH’s SUPPLEMENTARY INFORMATION: PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Total annual burden hours approach towards the achievement of its mission while ensuring good stewardship of taxpayer funds. It is not intended to outline the myriad of important research opportunities for specific diseases or conditions. Nor will it focus on the specific research missions of each component Institute, Center and Office. Those opportunities are found within strategic plans that are specific to an Institute, Center, or Office, or specific to a particular disease or disorder. (A list of Institute, Center, or Office-specific, topical, and other NIHwide or interagency strategic plans is available at https://report.nih.gov/ strategicplans/.) The Framework for the FY 2021–2025 NIH-Wide Strategic Plan, below, articulates NIH’s priorities in three key areas (Objectives): Biomedical and behavioral science research; scientific research capacity; and scientific integrity, public accountability, and social responsibility in the conduct of science. These Objectives apply across NIH. In addition, several Cross-Cutting Themes, which span the scope of these Objectives, are identified. NIH-Wide Strategic Plan Framework Cross Cutting Themes • Increasing, Enhancing, and Supporting Diversity • Improving Women’s Health and Minority Health, and Reducing Health Disparities E:\FR\FM\13FEN1.SGM 13FEN1 Federal Register / Vol. 85, No. 30 / Thursday, February 13, 2020 / Notices • Optimizing Data Science and the Development of Technologies and Tools • Promoting Collaborative Science • Addressing Public Health Challenges Across the Lifespan Objective 1: Advancing Biomedical and Behavioral Sciences • Driving Foundational Science • Preventing Disease and Promoting Health • Developing Treatments, Interventions, and Cures Objective 2: Developing, Maintaining, and Renewing Scientific Research Capacity • Cultivating the Biomedical Research Workforce • Supporting Research Resources and Infrastructure jbell on DSKJLSW7X2PROD with NOTICES Objective 3: Exemplifying and Promoting the Highest Level of Scientific Integrity, Public Accountability, and Social Responsibility in the Conduct of Science • Fostering a Culture of Good Scientific Stewardship • Leveraging Partnerships • Ensuring Accountability and Confidence in Biomedical and Behavioral Sciences • Optimizing Operations The NIH seeks comments on any or all of, but not limited to, the following topics: • Cross-Cutting Themes articulated in the framework, and/or additional cross-cutting themes that may be considered • NIH’s priorities across the three key areas (Objectives) articulated in the framework, including potential benefits, drawbacks or challenges, and other priority areas for consideration • Future opportunities or emerging trans-NIH needs NIH encourages organizations (e.g., patient advocacy groups, professional organizations) to submit a single response reflective of the views of the organization or membership as a whole. Responses to this RFI are voluntary and may be submitted anonymously. Please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your response. The Government will use the information submitted in response to this RFI at its discretion. The Government reserves the right to use any submitted information on public websites, in reports, in summaries of the state of the science, in any possible VerDate Sep<11>2014 18:34 Feb 12, 2020 Jkt 250001 resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements. This RFI is for informational and planning purposes only and is not a solicitation for applications or an obligation on the part of the Government to provide support for any ideas identified in response to it. Please note that the Government will not pay for the preparation of any information submitted or for use of that information. We look forward to your input and hope that you will share this RFI opportunity with your colleagues. Dated: February 7, 2020. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2020–02919 Filed 2–12–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Inherited Disease Research Access Committee. Date: March 6, 2020. Time: 11:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700 B Rockledge Drive, Room 3185, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Barbara J. Thomas, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 6700 B Rockledge Drive, Room 3185, Bethesda, MD 20892, 301–402–0838, barbara.thomas@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) PO 00000 Frm 00067 Fmt 4703 Sfmt 9990 8311 Dated: February 10, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–02915 Filed 2–12–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Conference Grants Applications. Date: March 11, 2020. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 6700B Rockledge Drive, Suite 3400, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Brian Hoshaw, Ph.D., Designated Federal Official, Division of Extramural Research, National Eye Institute, National Institutes of Health, 6700 B Rockledge Dr., Ste 3400, Rockville, MD 20892, 301–451–2020, hoshawb@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: February 10, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–02914 Filed 2–12–20; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 85, Number 30 (Thursday, February 13, 2020)]
[Notices]
[Pages 8310-8311]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02919]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information (RFI): Inviting Comments and Suggestions 
on a Framework for the NIH-Wide Strategic Plan for FYs 2021-2025

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This Request for Information (RFI) is intended to gather broad 
public input to assist the National Institutes of Health (NIH) in 
developing the NIH-Wide Strategic Plan for Fiscal Years (FYs) 2021-
2025. NIH invites input from stakeholders throughout the scientific 
research, advocacy, and clinical practice communities, as well as the 
general public, regarding the proposed framework for the FY 2021-2025 
NIH-Wide Strategic Plan. Organizations are strongly encouraged to 
submit a single response that reflects the views of their organization 
and their membership as a whole.

DATES: This RFI is open for public comment for a period of 6 weeks. 
Comments must be received by 11:59:59 p.m. (ET) on March 25, 2020 to 
ensure consideration.

ADDRESSES: All comments must be submitted electronically on the 
submission website, available at https://grants.nih.gov/grants/rfi/rfi.cfm?ID=101.

FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to: Marina 
Volkov, [email protected], 301.496.4147.

SUPPLEMENTARY INFORMATION: The purpose of the NIH-Wide Strategic Plan 
is to communicate how NIH will advance its mission to support research 
in pursuit of fundamental knowledge about the nature and behavior of 
living systems, and the application of that knowledge to enhance 
health, lengthen life, and reduce illness and disability.
    The current NIH-Wide Strategic Plan (available at: https://www.nih.gov/about-nih/nih-wide-strategic-plan), covering FYs 2016-2020, 
was submitted to Congress on December 15, 2015. As part of implementing 
the 21st Century Cures Act (Pub. L. 114-255), NIH will update its 
Strategic Plan every five years. The agency is currently developing an 
updated NIH-Wide Strategic Plan, for FYs 2021-2025, and anticipates 
releasing it in December 2020.
    The FY 2021-2025 NIH-Wide Strategic Plan will highlight NIH's 
approach towards the achievement of its mission while ensuring good 
stewardship of taxpayer funds. It is not intended to outline the myriad 
of important research opportunities for specific diseases or 
conditions. Nor will it focus on the specific research missions of each 
component Institute, Center and Office. Those opportunities are found 
within strategic plans that are specific to an Institute, Center, or 
Office, or specific to a particular disease or disorder. (A list of 
Institute, Center, or Office-specific, topical, and other NIH-wide or 
interagency strategic plans is available at https://report.nih.gov/strategicplans/.)
    The Framework for the FY 2021-2025 NIH-Wide Strategic Plan, below, 
articulates NIH's priorities in three key areas (Objectives): 
Biomedical and behavioral science research; scientific research 
capacity; and scientific integrity, public accountability, and social 
responsibility in the conduct of science. These Objectives apply across 
NIH. In addition, several Cross-Cutting Themes, which span the scope of 
these Objectives, are identified.

NIH-Wide Strategic Plan Framework

Cross Cutting Themes

 Increasing, Enhancing, and Supporting Diversity
 Improving Women's Health and Minority Health, and Reducing 
Health Disparities

[[Page 8311]]

 Optimizing Data Science and the Development of Technologies 
and Tools
 Promoting Collaborative Science
 Addressing Public Health Challenges Across the Lifespan

Objective 1: Advancing Biomedical and Behavioral Sciences

 Driving Foundational Science
 Preventing Disease and Promoting Health
 Developing Treatments, Interventions, and Cures

Objective 2: Developing, Maintaining, and Renewing Scientific Research 
Capacity

 Cultivating the Biomedical Research Workforce
 Supporting Research Resources and Infrastructure

Objective 3: Exemplifying and Promoting the Highest Level of Scientific 
Integrity, Public Accountability, and Social Responsibility in the 
Conduct of Science

 Fostering a Culture of Good Scientific Stewardship
 Leveraging Partnerships
 Ensuring Accountability and Confidence in Biomedical and 
Behavioral Sciences
 Optimizing Operations
    The NIH seeks comments on any or all of, but not limited to, the 
following topics:
 Cross-Cutting Themes articulated in the framework, and/or 
additional cross-cutting themes that may be considered
 NIH's priorities across the three key areas (Objectives) 
articulated in the framework, including potential benefits, drawbacks 
or challenges, and other priority areas for consideration
 Future opportunities or emerging trans-NIH needs
    NIH encourages organizations (e.g., patient advocacy groups, 
professional organizations) to submit a single response reflective of 
the views of the organization or membership as a whole.
    Responses to this RFI are voluntary and may be submitted 
anonymously. Please do not include any personally identifiable 
information or any information that you do not wish to make public. 
Proprietary, classified, confidential, or sensitive information should 
not be included in your response. The Government will use the 
information submitted in response to this RFI at its discretion. The 
Government reserves the right to use any submitted information on 
public websites, in reports, in summaries of the state of the science, 
in any possible resultant solicitation(s), grant(s), or cooperative 
agreement(s), or in the development of future funding opportunity 
announcements. This RFI is for informational and planning purposes only 
and is not a solicitation for applications or an obligation on the part 
of the Government to provide support for any ideas identified in 
response to it. Please note that the Government will not pay for the 
preparation of any information submitted or for use of that 
information.
    We look forward to your input and hope that you will share this RFI 
opportunity with your colleagues.

    Dated: February 7, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2020-02919 Filed 2-12-20; 8:45 am]
 BILLING CODE 4140-01-P